Strikingly, up-regulation of NG2/CSPG4 is tightly linked to loco-regional recurrence of the tumour, underscoring the potential of this biomarker to forcefully predict the clinical course of oral cavity HNSCC patients. Here, CSPG4 is linked to head and neck squamous cell carcinoma.